Key facts
- This page summarizes Jon P. Stonehouse's Form 4 filing for BIOCRYST PHARMACEUTICALS INC (BCRX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Sep 2026, 16:16.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $12,500.